Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.

NCT01644305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2018-06-27

No results posted yet for this study

Summary

The purpose of this study is to determine the plasma levels of GDF-9 and GDF-15, and their association with bone and cardiovascular parameters in patients with Polycystic Ovary Syndrome.

Conditions

  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • Ankara Education and Research Hospital

    lead OTHER_GOV

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-07-31
Completion
2013-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644305 on ClinicalTrials.gov